Actively Recruiting
The Jinling Cohort
Led by Nanjing Shihejiyin Technology, Inc. · Updated on 2023-08-25
15000
Participants Needed
2
Research Sites
256 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.
CONDITIONS
Official Title
The Jinling Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 45 and 75 years
- Willing and able to undergo blood sample collection, health questionnaires, and annual routine physical exams once a year for three consecutive years
- Resident of Nanjing
- Fully understand the study and able to provide written informed consent
You will not qualify if you...
- Pregnant women
- History of cancer or current cancer diagnosis
- History of organ transplant or prior non-autologous bone marrow or stem cell transplant
- Blood transfusion within 30 days before blood draw
- Acute infection or inflammation within 14 days before blood draw
- Use of medication with anti-tumor effects within 30 days before blood draw
- Unable to comply with study procedures as judged by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Nanjing Jiangbei People's Hospital
Nanjing, Jiangsu, China, 210000
Actively Recruiting
2
The Fourth Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210000
Actively Recruiting
Research Team
S
Shanshan Yang, Ph.D
CONTACT
X
Xuan Wang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here